Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients.

Por Romain, S., Chinot, O., Klijn, J. G., van Putten, W. L., Guirou, O., Look, M., Martin, P. M., Foekens, J. A.
Publicado em 1994

Clinical implications of quantitative real-time RT–PCR analysis of hTERT gene expression in human gliomas

Por Tchirkov, A, Rolhion, C, Kémény, J-L, Irthum, B, Puget, S, Khalil, T, Chinot, O, Kwiatkowski, F, Périssel, B, Vago, P, Verrelle, P
Publicado em 2003

P04.07 EXPRESSION PROFILE OF ANGIOGENIC FACTORS IN PAIRED INITIAL AND RECURRENT GLIOBLASTOMA

Por Tabouret, E., Tchoghandjian, A., Denicolai, E., Delfino, C., Metellus, P., Barrie, M., Boucard, C., Ouafik, L., Figarella-Branger, D., Chinot, O.
Publicado em 2014

P04.08 PLASMA LEVELS AND TUMOR TISSUE RNA OF MMP2 AND MMP9 EXHIBIT SIMILAR DISTRIBUTION IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA (GB)

Por Tabouret, E., Boudouresque, F., Denicolai, E., Barrié, M., Boucard, C., Metellus, P., Autran, D., Figarella-Branger, D., Ouafik, L., Chinot, O.
Publicado em 2014

P08.07 LEPTOMENINGEAL GLIOMATOSIS: A SINGLE INSTITUTION RETROSPECTIVE STUDY OF 31 PATIENTS

Por Autran, D., Tabouret, E., Barrié, M., Boucard, C., Terciolo, A., Loundou, A., Metellus, P., Dufour, H., Figarella-Branger, D., Chinot, O.L.
Publicado em 2014

P17.20 PATTERNS OF CARE AND OUTCOME FOR PATIENTS WITH RECURRENT GLIOBLASTOMA

Por De Cock, L., Sala, Q., Barrie, M., Boucard, C., Metellus, P., Tabouret, E., Padovani, L., Figarella-Branger, D., Dufour, H., Chinot, O.
Publicado em 2014

Summary version of the Standards, Options and Recommendations for the management of adult patients with intracranial glioma (2002)

Por Frappaz, D, Chinot, O, Bataillard, A, Ben Hassel, M, Capelle, L, Chanalet, S, Chatel, M, Figarella-Branger, D, Guegan, Y, Guyotat, J, Hoang-Xuan, K, Jouanneau, E, Keime-Guibert, F, Laforêt, C, Linassier, C, Loiseau, H, Maire, J P, Menei, P, Rousmans, S, Sanson, M, Sunyach, M P
Publicado em 2003